The excerpts from The New Yorker (below) may be read as a companion piece to the Atlantic article profiling Dr. John Ioannidis. However, the opening example that Lehrer uses to make the point that initial impressive positive research findings often weaken in time, perpetuates a myth about the new…
The re-prioritization of rapid approvals occurred at the expense of drug safety standards,
The first in the BBC-Panorama series elicited more than 65,000 emails and phone calls.The fourth report aired tonight, focuses on study #329, the largest of the Paxil pediatric trials. BBC will show evidence of how the published report of this trial was manipulated to deceive physicians about the safety and…
Readers of the New England Journal of Medicine should be forewarned: The information in the pages of the NEJM is tainted by industry influence, its professional and scientific integrity are tainted.
"Why are scientists coy about publishing negative data?
A Taxpayer-Funded Clinical Trial Registry Exists! Thu, 6 Oct 2005 A former FDA medical officer reports: A Taxpayer-Funded Clinical Trials Registry and Results Database: It already exists within the US Food and Drug Administration. But the agency keeps the vital information about drug safety secret and inaccessible. So, all the…
The Evidence base: rock of certainty or shifting sands? – BMJ Wed, 5 May 2004 Dr. John Dewhurst, has written an extraordinary article from his first-hand experience as a pharmaceutical company physician who discovered the disparity that exists between the claimed and actual evidence of drug effectiveness–and the reality-based severe,…
Int’l Registration of Clinical Research WHO Tue, 6 Apr 2004 On April 3, the World Health Organization (WHO) and Current Controlled Trials, Ltd (based in London, Philadelphia and Tokyo) announced that all randomized controlled clinical trials approved by the WHO ethics committee will be registered in a unique international registry…
“Black Hole” of medical research–Negative Results Don’t get Published – JAMA, WSJ Sat, 5 Jun 2004 “No one likes bad news. But in science, there is an ethical imperative to publish research, even if the findings aren’t what the researcher had hoped for.” The New York Times, which tends to…
“Drug Companies Should Make Their Studies Public” NYT Wed, 13 Aug 2003 Concealed and inaccessible research findings are undermining the integrity of medicine, the advancement of scientific knowledge, and most importantly, secrecy is putting people’s lives in jeopardy because prescribing doctors are ignorant about adverse – even lethal – drug…
British Psychiatrists Debate: “Clinical trials of antidepressant medications are producing meaningless results” Wed, 27 Aug 2003 “The fact that most people support the psychopharmacological orthodoxy is, in itself, no argument and it is important to examine the evidence before drawing conclusions.” The psychiatric establishment is on trial–its foundation and claimed…
Randomized Controlled Trials: Evidence Biased Psychiatry By David Healy, MD MRCPsych Introduction A new drug gets introduced to the market. It has been approved after stringent scrutiny by the FDA, which requires ever more convincing evidence that it works and that its safe. The new treatment will always cost more…
